Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin K A Thomson

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanismsBenjamin K A Thomson, Thomas D Nolin, Thomas J Velenosi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?Catherine M Clase, Rachel M Holden, Manish M Sood, et al.
Nephron. Clinical Practice|July 18, 2013
Frequent nocturnal hemodialysis associates with improvement of prolonged QTc intervalsBenjamin K A Thomson, Bogdan Momciu, Shih-Han S Huang, et al.
Scientific Reports|May 4, 2019
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney functionThomas J Velenosi, Benjamin K A Thomson, Nicholas C Tonial, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanismsBenjamin K A Thomson, Thomas D Nolin, Thomas J Velenosi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?Catherine M Clase, Rachel M Holden, Manish M Sood, et al.
Nephron. Clinical Practice|July 18, 2013
Frequent nocturnal hemodialysis associates with improvement of prolonged QTc intervalsBenjamin K A Thomson, Bogdan Momciu, Shih-Han S Huang, et al.
Scientific Reports|May 4, 2019
Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney functionThomas J Velenosi, Benjamin K A Thomson, Nicholas C Tonial, et al.
Pageof 2